Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals
    • Sun Pharma arm Taro...

    Sun Pharma arm Taro plans shares repurchase worth 250 million

    Written by savita thakur thakur Published On 2016-03-17T11:47:52+05:30  |  Updated On 17 March 2016 11:47 AM IST
    Sun Pharma arm Taro plans shares repurchase worth 250 million
    New Delhi : Drug major Sun Pharma's Israeli arm Taro Pharmaceutical Industries plans to buy back shares worth $250 million (over Rs 1,683 crore).

    The board of directors of Taro Pharmaceutical Industries on Wednesday approved a $250 million share repurchase authorisation of its ordinary shares.

    Repurchases may be made from time to time at the company's discretion, based on ongoing assessments of the capital needs of the business, the market price of its stock, and general market conditions, the company said in a statement.

    "No time period has been set for the repurchase programme, and any such programme may be suspended or discontinued at any time," Taro said.

    The repurchase authorisation enables it to purchase it's ordinary shares from time to time through open market purchases, negotiated transactions or other means in accordance with applicable securities laws or other restrictions, it added.

    Taro Pharmaceutical Industries develops, manufactures and markets generic and branded prescription and over-the-counter (OTC) pharmaceutical products.

    In 2010, Sun Pharma ending a three-year-long battle had acquired a controlling stake in Taro pursuant to entering an agreement with then promoters of Taro led by then Chairman Barrie Levitt in 2007.
    OTCover-the-counterSun PharmaTaro ledTaro Pharmaceutical
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok